Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - SANGAMO THERAPEUTICS, INC | sgmo-20201231xex321.htm |
EX-31.2 - EX-31.2 - SANGAMO THERAPEUTICS, INC | sgmo-20201231xex312.htm |
EX-31.1 - EX-31.1 - SANGAMO THERAPEUTICS, INC | sgmo-20201231xex311.htm |
EX-23.1 - EX-23.1 - SANGAMO THERAPEUTICS, INC | sgmo-20201231xexx231.htm |
EX-4.1 - EX-4.1 - SANGAMO THERAPEUTICS, INC | sgmo-20201231xexx41.htm |
10-K - 10-K - SANGAMO THERAPEUTICS, INC | sgmo-20201231.htm |
Exhibit 21.1
Subsidiaries of the Company
Gendaq Limited (U.K.)
Ceregene Inc. (Delaware)
Sangamo Therapeutics France S.A.S. (France)